Loss of HB-EGF in smooth muscle or endothelial cell lineages causes heart malformation

Area of Science:

• Cardiovascular Biology
• Developmental Biology
• Molecular Biology

Background:

• Epidermal growth factor (EGF) and ErbB family molecules are known to influence cardiac development and function.
• Heparin-binding EGF-like growth factor (HB-EGF) is a key member of the EGF family, but its specific role in heart development requires further investigation.

Purpose of the Study:

• To elucidate the function of HB-EGF in heart development by examining its role in smooth muscle and endothelial cell lineages.
• To determine the consequences of HB-EGF deficiency in these specific cell types on cardiac structure and survival.

Main Methods:

• Generation of lineage-specific HB-EGF knockout mice using the Cre/loxP system.
• Utilized SM22alpha and TIE2 promoters to target HB-EGF deletion in smooth muscle and endothelial cells, respectively.
• Phenotypic analysis of knockout mice, including assessment of heart valve morphology, postnatal survival rates, and cardiac structure.

Main Results:

• HB-EGF knockout mice exhibited enlarged heart valves, indicating a critical role in valve development.
• Over 50% of the knockout mice died within the first postnatal week, highlighting the essential nature of HB-EGF for early survival.
• Surviving HB-EGF knockout mice displayed cardiac hypertrophy, suggesting compensatory mechanisms or long-term functional impairments.

Conclusions:

• Expression of HB-EGF within smooth muscle and/or endothelial cell lineages is indispensable for proper mouse heart development.
• HB-EGF plays a vital role in maintaining cardiac function and preventing mortality during the critical early postnatal period.